Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction

par Shigeo Godo, Jun Takahashi, Satoshi Yasuda, Hiroaki Shimokawa
Publié 2021

Pathophysiology and Diagnosis of Coronary Functional Abnormalities

par Jun Takahashi, Akira Suda, Kensuke Nishimiya, Shigeo Godo, Satoshi Yasuda, Hiroaki Shimokawa
Publié 2021

A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system.

par Keiko Tano, Satoshi Yasuda, Takuya Kuroda, Hirohisa Saito, Akihiro Umezawa, Yoji Sato
Publié 2014

SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation

par Takuya Kuroda, Satoshi Yasuda, Shiori Tachi, Satoko Matsuyama, Shinji Kusakawa, Keiko Tano, Takumi Miura, Akifumi Matsuyama, Yoji Sato
Publié 2019

Low-intensity pulsed ultrasound therapy promotes recovery from stroke by enhancing angio-neurogenesis in mice in vivo

par Sadamitsu Ichijo, Tomohiko Shindo, Kumiko Eguchi, Yuto Monma, Takashi Nakata, Yoshihiko Morisue, Hiroshi Kanai, Noriko Osumi, Satoshi Yasuda, Hiroaki Shimokawa
Publié 2021

Identification of a Gene Encoding Slow Skeletal Muscle Troponin T as a Novel Marker for Immortalization of Retinal Pigment Epithelial Cells

par Takuya Kuroda, Satoshi Yasuda, Hiroyuki Nakashima, Nozomi Takada, Satoko Matsuyama, Shinji Kusakawa, Akihiro Umezawa, Akifumi Matsuyama, Shin Kawamata, Yoji Sato
Publié 2017

A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells

par Takamasa Hirai, Ken Kono, Rumi Sawada, Takuya Kuroda, Satoshi Yasuda, Satoko Matsuyama, Akifumi Matsuyama, Naoya Koizumi, Naoki Utoguchi, Hiroyuki Mizuguchi, Yoji Sato
Publié 2021

Association of PM2.5 exposure with hospitalization for cardiovascular disease in elderly individuals in Japan

par Toshiki Kaihara, Kihei Yoneyama, Michikazu Nakai, Takumi Higuma, Yoko Sumita, Yoshihiro Miyamoto, Mika Watanabe, Masaki Izumo, Yuki Ishibashi, Yasuhiro Tanabe, Tomoo Harada, Satoshi Yasuda, Hisao Ogawa, Yoshihiro J. Akashi
Publié 2021

Effects of temperature and humidity on acute myocardial infarction hospitalization in a super-aging society

par Takumi Higuma, Kihei Yoneyama, Michikazu Nakai, Toshiki Kaihara, Yoko Sumita, Mika Watanabe, Shunichi Doi, Yoshihiro Miyamoto, Satoshi Yasuda, Yuki Ishibashi, Masaki Izumo, Yasuhiro Tanabe, Tomoo Harada, Hisao Ogawa, Yoshihiro J. Akashi
Publié 2021

Weather temperature and the incidence of hospitalization for cardiovascular diseases in an aging society

par Kihei Yoneyama, Michikazu Nakai, Takumi Higuma, Kanako Teramoto, Mika Watanabe, Toshiki Kaihara, Yoko Sumita, Yoshihiro Miyamoto, Satoshi Yasuda, Yuki Ishibashi, Masaki Izumo, Yasuhiro Tanabe, Tomoo Harada, Hisao Ogawa, Yoshihiro J. Akashi
Publié 2021

Low-intensity pulsed ultrasound therapy suppresses coronary adventitial inflammatory changes and hyperconstricting responses after coronary stent implantation in pigs in vivo.

par Tasuku Watanabe, Yasuharu Matsumoto, Kensuke Nishimiya, Tomohiko Shindo, Hirokazu Amamizu, Jun Sugisawa, Satoshi Tsuchiya, Koichi Sato, Susumu Morosawa, Kazuma Ohyama, Tomomi Watanabe-Asaka, Moyuru Hayashi, Yoshiko Kawai, Jun Takahashi, Satoshi Yasuda, Hiroaki Shimokawa
Publié 2021

Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib

par Toshifumi Tada, Takashi Kumada, Atsushi Hiraoka, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Kazuya Kariyama, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Shinya Fukunishi, Hideko Ohama, Kazuhito Kawata, Joji Tani, Shinichiro Nakamura, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Tanaka Takaaki, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Kouji Joko, Yohei Koizumi, Yoichi Hiasa, Real-life Practice Experts for HCC (RELPEC) Study Group and the HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Publié 2021

Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study

par Atsushi Hiraoka, Takashi Kumada, Toshifumi Tada, Joji Tani, Kazuya Kariyama, Shinya Fukunishi, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Kazuhito Kawata, Satoshi Yasuda, Hidenori Toyoda, Tomoko Aoki, Takaaki Tanaka, Hideko Ohama, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Taeang Arai, Tomomi Okubo, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Koji Joko, Yoichi Hiasa, Masatoshi Kudo, The Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Publié 2021